Literature DB >> 16820940

Ouabain chronic infusion enhances the growth and steroidogenic capacity of rat adrenal zona glomerulosa: the possible involvement of the endothelin system.

Giuliano Neri1, Renzo De Toni, Cinzia Tortorella, Piera Rebuffat, Sergio Bova, Gabriella Cargnelli, Lucia Petrelli, Raffaella Spinazzi, Gastone G Nussdorfer.   

Abstract

Ouabain, an inhibitor of the Na+/K+-ATPase, has been reported to affect the secretory activity of the adrenal cortex, and especially of zona glomerulosa (ZG). However, conflicting results were obtained, depending on the experimental condition used since ouabain appears to interact with angiotensin-II (Ang-II) and its action to be influenced by the electrolyte balance. Hence, we investigated the effects of prolonged (4-month) infusion with ouabain on the rat adrenal cortex. Ouabain raised the plasma concentrations of aldosterone, corticosterone and endothelin-1 (ET-1), without affecting either systolic blood pressure (SBP) or plasma renin activity (PRA). The treatment caused a marked hypertrophy of ZG and ZG cells, which mainly ensued from increases in the volume of the mitochondrial and smooth-endoplasmic-reticulum compartments, where the enzymes of steroid synthesis are located. Conversely, the volume of the lipid-droplet compartment, which stores cholesterol utilized in steroid-hormone production, underwent a striking decrease. Zona fasciculata and its parenchymal cells were not affected. Basal and maximally agonist (ACTH, Ang-II and ET-1)-stimulated in vitro mineralocorticoid secretion from adrenal slices was also notably enhanced by ouabain administration. Collectively, these findings indicate that prolonged treatment with ouabain selectively stimulates the growth and steroidogenic capacity of the rat adrenal ZG. The possibility that the activation of the renin-angiotensin system may be involved in this effect of ouabain is ruled out by the lack of significant changes in SBP and PRA. Instead, our results suggest the possible involvement of ET-1, the plasma level of which is elevated in ouabain-infused rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820940

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

1.  Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

Authors:  Felix Beuschlein; Sheerazed Boulkroun; Andrea Osswald; Thomas Wieland; Hang N Nielsen; Urs D Lichtenauer; David Penton; Vivien R Schack; Laurence Amar; Evelyn Fischer; Anett Walther; Philipp Tauber; Thomas Schwarzmayr; Susanne Diener; Elisabeth Graf; Bruno Allolio; Benoit Samson-Couterie; Arndt Benecke; Marcus Quinkler; Francesco Fallo; Pierre-Francois Plouin; Franco Mantero; Thomas Meitinger; Paolo Mulatero; Xavier Jeunemaitre; Richard Warth; Bente Vilsen; Maria-Christina Zennaro; Tim M Strom; Martin Reincke
Journal:  Nat Genet       Date:  2013-02-17       Impact factor: 38.330

Review 2.  Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas.

Authors:  Celso E Gomez-Sanchez; Maniselvan Kuppusamy; Elise P Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2014-12-10       Impact factor: 4.102

Review 3.  Gene mutations that promote adrenal aldosterone production, sodium retention, and hypertension.

Authors:  Andreas G Moraitis; William E Rainey; Richard J Auchus
Journal:  Appl Clin Genet       Date:  2013-12-24

Review 4.  Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.

Authors:  Mishghan Zehra; James C Curry; Sneha S Pillai; Hari Vishal Lakhani; Cory E Edwards; Komal Sodhi
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

5.  ATP1A1 Mutant in Aldosterone-Producing Adenoma Leads to Cell Proliferation.

Authors:  Kazuhiro Kobuke; Kenji Oki; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Kiyotaka Itcho; Haruya Ohno; Gaku Nagano; Yoko Yoshii; Ryuta Baba; Takaya Kodama; Koji Arihiro; Noboru Hattori; Masayasu Yoneda
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

Review 6.  Update on angiotensin II: new endocrine connections between the brain, adrenal glands and the cardiovascular system.

Authors:  Frans H H Leenen; Mordecai P Blaustein; John M Hamlyn
Journal:  Endocr Connect       Date:  2017-08-30       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.